Productos Finales de Glicación Avanzada/análisis; Espectrometría de Masas/métodos; Proteínas/análisis; Productos Finales de Glicación Avanzada/química; Humanos; Oxidación-Reducción; Proteínas/química

3-NT; 3-nitrotyrosine; 3DG-H; 3DG-H1 (N(δ)-[5-(2,3,4-trihydroxybutyl)-5-hydro-4-imidazolon-2-yl]ornithine) and related structural isomers 3DG-H2 and 3DG-H3 see [1]; 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate; AASA; AGE; AOPP; AQC; BNX; BUL; CEL; CML; CRF; Dicarbonyl stress; ESI; FCR; FL; FN3K; FN3KRP; G-H1; GOLD; GSA; HD; LC-MS/MS; LDL; MALDI; MG; MG-H1; MOLD; MRM; MSR; Mass spectrometry; MetSO; Methylglyoxal; N(δ)-(5-hydro-4-imidazolon-2-yl)ornithine; N(δ)-(5-hydro-5-methyl-4-imidazolon-2-yl)ornithine; N(ε)-carboxymethyl-lysine; N(ε)-fructosyl-lysine; N-formylkynurenine; NFK; Nε-(1-carboxyethyl)lysine; Oxidative stress; PD; Protein glycation; Protein oxidation; SAF; TFA; UPLC; advanced glycation endproduct; advanced oxidation protein product; aminoadipic semialdehyde; bilateral nephrectomy; bilateral ureteral ligation; chronic renal failure; electrospray ionisation; fractional clearance rate; fructosamine-3-kinase; fructosamine-3-kinase related protein; glutamic semialdehyde; glyoxal-derived lysine dimer, 1,3-di(N(ε)-lysino)imidazolium salt; hemodialysis; liquid chromatography-tandem mass spectrometry; low density lipoprotein; matrix assisted laser desorption ionisation; methionine sulfoxide; methionine sulfoxide reductase; methylglyoxal; methylglyoxal-derived lysine dimer, 1,3-di(N(ε)-lysino)-4-methyl-imidazolium salt; multiple reaction monitoring; peritoneal dialysis; skin autofluorescence; trifluoroacetic acid; ultra high performance liquid chromatography